A ten-year-old Golden Retriever wobbles on the way back from the garden, lies down heavily on the kitchen floor, and won't get up. Her gums look washed out. Twenty minutes later she stands, walks to her water bowl and drinks. By the time the vet's office opens she seems almost normal, and the whole thing starts to feel like it might have been nothing.

It was not nothing. That pattern — sudden weakness, pale gums, apparent recovery — is one of the most characteristic openings of hemangiosarcoma, and it happens because a tumour bled into the abdomen and then temporarily stopped. Of all the cancers dogs get, this is the one most likely to give owners no warning at all until the day it becomes an emergency. Understanding it won't prevent it, but it can change what you do in that critical hour.

What Hemangiosarcoma Actually Is

Hemangiosarcoma (HSA) is a malignant tumour of the cells that line blood vessels — the endothelium. Because blood vessels run everywhere, the tumour can arise almost anywhere, but four sites dominate: the spleen, the right atrium of the heart, the liver, and the skin and tissue just beneath it.

Its defining feature is structural. HSA builds chaotic, poorly formed blood-filled channels rather than proper vessels, so the mass is essentially a fragile blood-filled sac attached to an organ. It grows without pressing on anything, without causing pain, and without producing the appetite loss or vomiting that would send an owner to the vet. Then a section of that fragile wall gives way, and the dog bleeds internally.

Small bleeds often seal themselves. The dog collapses, the body reabsorbs the blood over hours to days, and the animal seems to recover — sometimes with nothing more than a day of tiredness and pale gums. A large bleed does not seal itself, and that is a genuine life-threatening emergency.

The disease is also aggressive at a microscopic level. Because it originates in the bloodstream's own plumbing, tumour cells spread early and widely — most often to the liver, lungs, omentum and heart. In many dogs, metastasis has already occurred by the time the primary mass is found.

Which Dogs Are at Risk

Hemangiosarcoma is not common as a share of all canine tumours — roughly 2% by most estimates — but it is heavily concentrated in certain breeds, and it is a leading cause of death in some of them.

Golden Retrievers carry the most-studied risk. In the Morris Animal Foundation's Golden Retriever Lifetime Study, an analysis published in Veterinary and Comparative Oncology in 2023 found hemangiosarcoma diagnosed in 233 of 3,044 enrolled dogs — an incidence of about 1.1 cases per 100 dog-years. Long-standing breed health surveys have put the lifetime risk in Goldens at roughly one in five, which is why the breed appears in nearly every research programme targeting this cancer.

Other over-represented breeds include German Shepherds, Labrador Retrievers, Boxers, Portuguese Water Dogs and Flat-Coated Retrievers. Most affected dogs are middle-aged to older — commonly eight to thirteen years — and medium to large in size, though the disease is not restricted to any of these groups.

Skin-based (dermal) hemangiosarcoma follows a different pattern. It is linked to ultraviolet exposure and shows up in thin-coated, lightly pigmented dogs — Whippets, Dalmatians, Pit Bull Terriers, Basset Hounds — typically on the belly, flank or inner thigh, where sun exposure is highest during sunbathing. This is the one form with a genuinely encouraging outlook, which we'll come back to.

Signs Worth Acting On

The frustrating truth is that most internal hemangiosarcomas produce no signs at all until a bleed occurs. But there are things that do show up, often intermittently, in the weeks before:

If your dog collapses and then recovers, that recovery is not reassurance — it is a window. Go to a vet or emergency clinic the same day, not next week. A ten-minute abdominal ultrasound or a packed cell volume test can find free blood in the abdomen long before the next, larger bleed.

The Splenic Mass Problem

Most owners meet hemangiosarcoma through the phrase "there's a mass on the spleen". The immediate question is always the same: is it cancer?

Vets long used a rule of thumb known as the double two-thirds rule — about two-thirds of splenic masses are malignant, and about two-thirds of those are hemangiosarcoma. More recent data suggests that is too pessimistic. A study of 182 dogs undergoing splenectomy at a surgical specialty clinic, published in PLOS One in 2024, found only 42.3% of splenic lesions were malignant and hemangiosarcoma accounted for 32.4% of cases. The remainder were benign: hematomas, nodular hyperplasia, abscesses or hemangiomas.

The single biggest modifier is whether the dog is bleeding. Reviews of the published evidence suggest a splenic mass with no free abdominal blood has roughly a two-in-three chance of being benign, while one presenting with hemoabdomen is far more likely to be malignant. That difference matters enormously to families weighing surgery.

Critically, no imaging test can distinguish hemangiosarcoma from a benign hematoma. Ultrasound and CT describe the mass; only histopathology after removal gives an answer. Fine needle aspiration of a splenic mass is generally avoided because of bleeding risk. What imaging is good for is staging — checking the liver, chest and heart before anyone commits to surgery.

Treatment, and What It Honestly Buys

Emergency stabilisation comes first in a bleeding dog: intravenous fluids, sometimes a blood transfusion, and pain relief. Surgery to remove a bleeding spleen (splenectomy) is the definitive step, and it is often done urgently.

Splenectomy alone stops the bleeding and removes the primary tumour, but does nothing about microscopic spread. In a study of 208 dogs published in JAVMA in 2015, median survival after splenectomy alone was approximately 1.6 months.

Splenectomy plus chemotherapy is the standard of care. Doxorubicin-based protocols typically extend median survival to around five to seven months, with roughly 10% of dogs reaching a year. In that same study, clinical stage was the only factor significantly associated with survival — dogs with disease already visible in the liver or elsewhere do considerably worse. Metronomic protocols using low-dose oral cyclophosphamide are sometimes added, and some evidence suggests combining conventional and metronomic approaches outperforms either alone.

Cardiac hemangiosarcoma, usually in the right atrium, presents differently: fluid builds in the sac around the heart, compressing it (cardiac tamponade). Draining that fluid — pericardiocentesis — relieves the crisis, and pericardectomy plus chemotherapy is used in selected cases, but the prognosis is generally poorer than for splenic disease.

Dermal hemangiosarcoma is the exception worth knowing about. When the tumour is confined to the skin layer itself and is fully excised with clean margins, survival is often measured in years. Once it invades the subcutaneous tissue or muscle beneath, behaviour becomes much more like the internal form.

Dogs generally tolerate veterinary chemotherapy far better than people expect. Doses are calibrated for quality of life rather than maximum intensity, and severe side effects are uncommon.

Can Anything Be Done in Advance?

There is no proven screening programme, and no way to prevent internal hemangiosarcoma. Some owners of high-risk breeds opt for an annual abdominal ultrasound from around eight years of age, sometimes with an echocardiogram. This is not standard advice and its benefit isn't established, but it can find a small splenic mass while a dog is stable rather than in shock — and elective splenectomy is a far safer operation than emergency splenectomy in a bleeding patient. It is a reasonable conversation to have with your vet if you own a Golden Retriever or German Shepherd entering their senior years.

For dermal hemangiosarcoma, prevention genuinely applies: limit sunbathing on hot tiles and paving during peak hours, and consider dog-safe sunscreen or a light shirt for pale, thin-coated dogs.

Research is active and well funded. The AKC Canine Health Foundation and Morris Animal Foundation have both invested heavily in this disease, and work on early-detection blood tests and immunotherapy protocols is ongoing. If your dog is diagnosed, asking an oncologist about open clinical trials is worthwhile.

What to Take Away

Hemangiosarcoma is a hard disease, and no honest article can dress it up. What it can do is shift two decisions. First: a collapse that resolves is still an emergency — the recovery is the tumour clotting, not the problem going away. Second: a splenic mass is not automatically a death sentence. Nearly six in ten turn out to be benign, and the only way to know is to remove it and have it examined.

Beyond that, the ordinary things matter more than they seem. Know what your dog's gums look like when they're healthy. Take a photo of any new lump with a coin beside it for scale. And keep up with senior wellness checks, because the day this cancer announces itself, the head start is measured in hours.